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SUMMARY A large kindred with X-linked retinitis pigmentosa (XLRP) was investigated clinically
and by means of genetic linkage with a view to developing methods of carrier detection and early
diagnosis. A restriction fragment length polymorphism, identified by recombinant DNA probe
L1.28, showed close genetic linkage to XLRP in this kindred and is a potentially useful marker for
the purposes of genetic counselling.
In 1965 a family was described, consisting of seven
daughters and three sons, whose father had died after
being certified blind from an unknown cause.' The
three sons were normal and two had normal children;
the third was unmarried. Each of the seven daughters
had one or more sons suffering from retinitis pigmen-
tosa (10 in all). Since then two of their daughters have
had affected sons (Fig. 1).
Initially there was some doubt whether this family
should be classified as X-linked retinitis pigmentosa
(XLRP), as in no case did the carriers show a tapetal
reflex, which was believed at that time to be the
characteristic fundus appearance of the carrier state.
Correspondence to Dr M Jay, Moorfields Eye Hospital, City Road,
London ECIV 2PD.
In addition several of the proved carriers showed
retinal pigment epithelial changes with associated
visual loss, which was severe in some cases. It has
been recognised since then that female carriers may
show changes other than a tapetal reflex and may
have a visual deficit.' The pattern of inheritance in
this kindred, associated with severe visual deficit and
choroidal atrophy in advanced disease in affected
males and variable visual function in the females, is
compatible with a diagnosis of XLRP. It is reason-
able to assume that the blind progenitor of this family
(I/1) suffered from XLRP, which has therefore now
occurred in four generations.
X-linked retinitis pigmentosa is due to an abnor-
mal gene on an X chromosome. Males with one
Ill
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A;'
Pedigree offamily RP22.
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Fig. 2a Fig. 2b
Fig 2c Fig. 2d
Fig. 2 Fundus paintings ofaffected males: (a) I1130 aged3 years, (b) III122 aged 8years, (c) III121 aged 1Oyears,
(d) III126 aged 11 years, (e) IIIII aged30 years.
abnormal gene, whose normal chromosome comple-
ment includes one X and one Y chromosome, always
express the disease. Affected males usually have
night blindness in early childhood. When the disease
has been present for some years, there is a character-
istic fundus picture showing bone corpuscle pigmen-
tation, attenuated retinal vessels, and pallor of the
optic disc (Fig. 2); the diagnosis may be confirmed by
electrodiagnostic tests. In some families it would be
wrong to exclude the diagnosis before the early teens.
In X-linked disease there is no father to son
transmission, since sons receive their X chromosome
from their mother, but every daughter of an affected
male receives an X chromosome from her father and
is a carrier, termed an obligate heterozygote. In the
absence of a corroborative family history mothers of
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Fig. 2c
two or more affected males are also obligate hetero-
zygotes, but mothers of one affected male are termed
presumptive heterozygotes unless there are signs of
the carrier state. The daughters of obligate hetero-
zygotes are termed possible heterozygotes if they are
clinically normal and obligate heterozygotes if they
are clinically abnormal. XLRP is transmitted by
heterozygotes, who have a 50% risk of having
affected sons and the same risk of having daughters
who will be carriers.
There is a wide spectrum in the expression of
clinical signs in heterozygotes, which has been
ascribed to the effect of random inactivation of the X
chromosome.5 According to the Lyon hypothesis one
of the two X chromosomes of the normal female is
inactivated early in embryogenesis. This inactivation
occurs at random, and the inactivated X chromo-
some, which forms the Barr body, may be maternal
or paternal in origin. Once inactivation has taken
place, the daughter cells will retain the same active X
chromosome. In particular, in a carrier female the
cells which are destined to form the retina will
comprise a proportion with a maternally derived
active X chromosome carrying the gene for XLRP if
she is the daughter of a heterozygote, and a propor-
tion with a paternally derived active X chromosome
carrying the gene for XLRP if she is the daughter of
an affected male. These proportions will vary from
one carrier to another, as a result of random inactiva-
tion of the X chromosome. This will result in
symptoms having a variable age of onset or being
absent altogether, and a clinical picture which can
vary from one that is occasionally almost as severe as
in the affected male, to cases where the retina, by
chance, consists largely of cells in which only the
normal X chromosome is active and no visual deficits
are manifest.
The detection of the heterozygous state ofXLRP is
often very difficult, but several methods have proved
Fig. 3a (right) Fig. 3a (left)
Fig. 3 Fundus paintings ofobligate heterozygotes: (a) I116 aged 43 years, right and left eyes, (b) II13 aged54years, right
and left eyes, (c) IIII aged57years, rightand lefteyes.
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helpful. Fundus changes can be identified in some
carriers. A tapetal reflex or widespread retinal pig-
ment epithelial changes with pigment migration are
easily detected, but in most carriers the changes
consist of small patches of pre-equatorial pigment
epithelial thinning with or without pigment migra-
tion, or a grey appearance of the retinal pigment
epithelium may also occur (Fig. 3). These latter
changes may be slight, and especially in a blue-eyed
individual the differentiation between a normal and
an abnormal appearance of the retinal pigment
epithelium may be difficult. Abnormalities in the
electroretinogram (increase of the time to peak of the
response to white light flickering at 30 Hz and/or a
decrease in the amplitude of the scotopic b wave)
have been demonstrated,6 but the detection rate of
carriers by this method is only 50%.7 Variations from
normal in flicker sensitivity have also been found
both scotopically8 and photopically,9 but with this test
only 60% of carriers are detected.
It is apparent therefore that more reliable and
objective means of detecting the carrier state in an
Fig. 3b (right) Fig. 3b (lcft)
Fig. 3c (right)
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individual female would be helpful to the clinician.
Linkage studies seek to detect the presence of the
disease by identifying a marker situated so close to
the disease gene that the risk of crossover is
minimal."' This method has the advantage that it can
be performed at any age, since the genotype is
established at conception and remains fixed through-
out life. In the case of linkage markers identified by
means of recombinant DNA probes there is the
additional advantage of being independent of X
chromosomal inactivation.
An X chromosome-specific recombinant DNA
probe has been used that is specific to a site on the
short arm of the X chromosome. The probe is a small
sequence of DNA obtained by digestion of DNA
from normal X chromosomes and cloned in a plasmid
vector in order to provide sufficient quantities in a
stable form for routine use. The linkage 'marker' is a
variant nucleotide base (or bases), in the sequences
flanking the probe, that occurs in a significant
proportion of the population. The variant site can be
detected only if it leads to a loss of one of the
recognition sequences of a restriction endonuclease
that normally cuts double-stranded DNA wherever it
recognises a particular combination of 4-6 nucleo-
tide bases. After electrophoretic separation of the
endonuclease-digested DNA fragments the loss of a
cleavage site is detected as an altered fragment length
(restriction fragment length polymorphism
RFLP) by hybridisation to the radioactively label-
led probe. It is the availability of large numbers of
chromosome specific DNA probes, many of which
can locate RFLP in nearby sequences, that makes it
possible to map genes and develop RFLPs close
enough to be used for presymptomatic diagnosis."
In the present study females suspected of carrying
the gene were investigated by several techniques in
order to assess the probability of the heterozygous
state being present. Blood from these females and
other close relatives informative for linkage was
subjected to analysis in an effort to find a linkage
marker for the disease.
Material and methods
Ten females from the family were examined and
tested, all of whom were the daughters of obligate
heterozygotes. A history was taken and an ocular
examination performed. Heterozygotes were identi-
fied by genetic criteria and recording ocular func-
tions, including an electroretinogram (ERG), by the
technique described by Arden et al.,7 and flicker
thresholds as described by Tyler and colleagues. 12 13
Blood was taken from these 10 females and from a
large number of other family members. DNA was
extracted by the method of Kunkel and colleagues. 14
It was digested to completion with the restriction
endonuclease TaqI and photographed after electro-
phoresis in 0-8% agarose gels and staining with
ethidium bromide. Gel DNA was denatured in
alkali, neutralised, and transferred to nitrocellulose
filters by the method of Southern.'5 Filters were
dried, baked, and hybridised overnight at 65°C in the
presence ofDNA from probe Li.28 labelled with 32P_
dTTP by nick translation. Filters were placed next to
an intensifier screen and exposed to x-ray film for 3-7
days. L1.28 is a random X-chromosome specific
sequence cloned in plasmid pBR322 and isolated
from a genomic library by Pearson and his col-
leagues16; it has been shown to be located close to
band Xpll.3 on the short arm of the X chromosome.
Linkage was analysed by means of the computer
program LIPED. 17
Results
CLINICAL AND ELECTRODIAGNOSTIC STUDIES
The fundus appearance and electroretinographic and
flicker results are summarised in Table 1. All cases
were asymptomatic and had a normal visual acuity.
Six of the 10 were thought to have an abnormal
fundus appearance, and two of these were obligate
heterozygotes by definition, having affected sons.
The fundus changes consisted of patchy retinal pig-
ment epithelial atrophy in the periphery with or
without pigment migration. Only two of the five
tested showed an abnormality on flicker testing, and
this consisted of a uniform reduction in sensitivity
across the whole frequency range (in which flicker
can be detected) in the peripheral field. An ERG was
recorded from three subjects and all were within
normal limits, although one showed a low normal
scotopic b wave amplitude. It was considered on the
basis of these results alone that six of the 10 persons
tested were presumptive heterozygotes.
Table 1 ERG, flicker sensitivity, andfundus appearance in
members offamily
Pedigree ERG Flicker Fundi
Number
HIM/3 - Normal Abnormal
HII/4 - Abnormal in periphery Abnormal
III/11 * Normal - Abnormal
III/13 Normal - Abnormal
(but low b wave)
III/15 - - Normal
III/18 - - Abnormal
III/24 - Normal Normal
III/27 Normal - Normal
III/28 - Normal Normal
III/29 - Abnormal in periphery Abnormal
*Obligate heterozygote, having an affected son.
- Not done.
344
A genetic linkage study ofa kindred with X-linked retinitispigmentosa
LINKAGE STUDIES
The results of the linkage studies with L1.28 are
shown in Table 2 and Fig. 4. The two marker alleles
are labelled Al and A2, corresponding to DNA
restriction fragments of length 12 kilobases (kb) and
9 kb respectively. It can be seen that all seven
obligate heterozygotes in generation II carried allele
A2 and at least six were heterozygous (Al-2) so that
their offspring were informative for linkage. This
means that the cosegregation or otherwise of alleles
Al and A2 with XLRP can be observed in their
offspring. Allele A2 was found to be associated with
XLRP in all 10 affected males and obligate heter-
ozygous females in generation III, while allele Al
was associated with the seven tested unaffected males
in generations II and III. It was assumed for the
purpose of this study that 'at risk' females in genera-
tion III showing the characteristic fundus changes of
carrier status and supported by other investigative
techniques were presumptive carriers. Two 'at risk'
females, shown to be carriers by these criteria, also
received allele A2 from their mother, consistent with
linkage between this allele and XLRP. However, two
females (III/13 and III129) showed fundus changes
consistent with the carrier state and yet had marker
status Al-1. Recombination may therefore have
occurred between the XLRP and L1.28 loci in these
cases. Four 'at risk' females in generation III were
found to have normal results by fundus examination
and other tests (Table 1), two of whom had alleles
Al-1 and two of whom had Al-2 (allele A2 from
mother). Since X-inactivation may lead to false
negative results in 'at risk' females, the genetic status
of females not manifesting the changes of carrier
status was not inferred for the purposes-of the linkage
study.
The linkage results have been analysed both
including and excluding the results from carrier
females diagnosed clinically (Table 2). In both cases
it is likely that probe L1.28 is closely linked to XLRP
Table 2 Linkage dataforXLRP
RP22 AllXLRP
Males only All Males only All
LODmax 5.10 3-78 6-32 6-81
Omax 0 00 0 09 0 00 0-05
Omean 0 05 0-13 0-04 0-08
95% limits 0-0-0-19 0-02-0-30 0.0-0.15 0 01-0-19
Summary of the results of linkage analysis between L1.28 and XLRP
in RP22 alone and combined with other XLRP families tested. The
maximum likelihood (0.0 and mean (Omnan) values of the recom-
bination fraction are shown together with the LOD scores corres-
ponding to Omax and the 95% confidence limits on 0. The analysis of
the data used clinical information from males only and from males
plus females identified as carriers on testing.
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Fig. 4 TaqI endonuckease digested DNAfrom members of
an RP22family, probed with recombinantDNA clone
LJ.28. The mother (1/6) is heterozygousforthe LJ.28
polymorphism, since she shows two restrictionfragments
with bands atl12 kilobases (kb; Al) and 9kb (A2). The two
affectedsons (1II/20, III/21) have theA2 allele, and the
unaffected son (I1I/23) has theAlI allele. The daughter
(III/24) showed no abnormality on clinical testing and is
homozygousforalleleAl.
with maximum LOD scores greater than 3 at a
distance less than 10 centimotgans (cM). This com-
pares with the genetic length of the X chromosome of
about 250 cM.'81 The current status of the linkage
results in RP22 combined with other XLRP families
is also shown in Table 2. The maximum likelihood
value of the recombination fraction is 0-O5, and the
upper 95% confidence limit is 0-19, indicating that
the error due to recombination is very unlikely to
exceed-20%.
Discussion
CLINICAL RESULTS
The females who were examined as part of this study
were seen over a period of several years, and hence
the investigative techniques used to try and ascertain
their genetic status have varied. The results obtained,
however, serve to emphasise the low detection rate of
the methods available at present. In our hands fundus
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examination still remains the most reliable means of
diagnosis of the carrier state, especially within the
context of a family history of X-linked retinitis
pigmentosa. The detection of X-linked disease in an
isolated individual and in the absence of a corrobora-
tive family history is at present extremely difficult and
in some cases may be impossible.
LINKAGE RESULTS
Analysis of the linkage results in this family (identi-
fied at Moorfields Eye Hospital as RP22) suggests
that there is close linkage between recombinant
DNA probe L1.28 and XLRP. Similar results have
been found in four other XLRP families,'920 which is
consistent with the gene in affected members of
family RP22 being either identical with or closely
linked to that causing XLRP in other families. The
combined data from all families give 95% confidence
limits for the distance between L1.28 and XLRP of
1-20 cM (0=0.01-0-19) and a minimum error
(mean) value of the recombination fraction of 0-08,
representing about 92% accuracy. The assignment of
the L1.28 locus to the proximal short arm of the X
chromosome (in the region ofband Xpl 1.3), suggests
that the XLRP gene is in the same region. At present
only some 40% of XLRP families are informative for
the L1.28 polymorphism, and work is under way to
try to extend this to a greater proportion of families.
A predictive test with accuracy greater than 92% is
most likely to be achieved by a combination of probes
flanking the XLRP locus, though the ordering of
closely linked loci is problematical. In addition to
refining genetic distances one further source of
uncertainty must be dealt with before the L1.28
polymorphism can be used clinically in all families,
namely, the possibility of genetic heterogeneity. This
problem does not arise with family RP22, within
which linkage has been established, but it may do
with other XLRP kindreds in which the possibility of
XLRP loci not linked to L1.28 cannot be discounted
until several- more independent families have been
analysed.
COMBINED USE OF CLINICAL AND LINKAGE DATA
IN XLRP CARRIER DETECTION
The use of information based on linked genetic
markers as an aid in the detection of heterozygotes in
XLRP is of potential importance, especially since
DNA polymorphisms are unaffected by X chromo-
some inactivation and are independent of age. As
information from genetic linkage and from clinical
tests is essentially independent, it should be possible
to combine the two sets of information quantitatively
to allow a more accurate prediction than is possible
from either set of data alone. This is already possible
for such disorders as the X-linked muscular dystro-
phies, but unfortunately no accurate estimates exist
for the likelihood of an XLRP heterozygote being
classified as normal on the basis of clinical tests.
Until such information exists it is probably prefer-
able to regard genetic linkage as strongly supportive
of clinical tests when both predict the heterozygous
state, while a prediction of normality would give a
comparably strong reassurance, with an error
unlikely to exceed 10%. In individuals at high genetic
risk who show unequivocal clinical features of the
heterozygous state, but are predicted by linkage to be
normal (for example, III/13 and III/29 in the present
kindred), it is advisable to rely on the clinical
evidence. Comparable caution is wise in advising
those clinically normal female relatives whose
genetic linkage evidence predicts that they have
received the XLRP gene.
Where an obligate or presumptive heterozygote is
pregnant and the fetus is known to be male, genetic
linkage data may allow prediction as to whether the
fetus has or has not inherited XLRP. Since both fetal
sex and fetal DNA polymorphisms (including L1.28)
can be reliably detected by chorion biopsy in the first
trimester of pregnancy, it is important that those
women in whom the prediction could be applied and
who would wish for such testing are fully informed
and investigated prior to embarking on a pregnancy.
Finally, it should be stressed that application of
genetic linkage in prediction requires study of the
family unit, not just an individual, an added factor in
favour of studies being done before they are actually
needed in making decisions regarding childbearing.
Since full accuracy of prediction may require the
availability of affected individuals or spouses in older
generations, serious consideration should be given to
obtaining samples from such individuals during their
lifetimes, so that the opportunity for prediction in the
younger generations is not lost.
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